297 related articles for article (PubMed ID: 32082606)
1. Probiotics and oxytocin nasal spray as neuro-social-behavioral interventions for patients with autism spectrum disorders: a pilot randomized controlled trial protocol.
Kong XJ; Liu J; Li J; Kwong K; Koh M; Sukijthamapan P; Guo JJ; Sun ZJ; Song Y
Pilot Feasibility Stud; 2020; 6():20. PubMed ID: 32082606
[TBL] [Abstract][Full Text] [Related]
2. Probiotic and Oxytocin Combination Therapy in Patients with Autism Spectrum Disorder: A Randomized, Double-Blinded, Placebo-Controlled Pilot Trial.
Kong XJ; Liu J; Liu K; Koh M; Sherman H; Liu S; Tian R; Sukijthamapan P; Wang J; Fong M; Xu L; Clairmont C; Jeong MS; Li A; Lopes M; Hagan V; Dutton T; Chan SP; Lee H; Kendall A; Kwong K; Song Y
Nutrients; 2021 May; 13(5):. PubMed ID: 34062986
[TBL] [Abstract][Full Text] [Related]
3. Carbon monoxide (CO) correlates with symptom severity, autoimmunity, and responses to probiotics treatment in a cohort of children with autism spectrum disorder (ASD): a post-hoc analysis of a randomized controlled trial.
Sherman HT; Liu K; Kwong K; Chan ST; Li AC; Kong XJ
BMC Psychiatry; 2022 Aug; 22(1):536. PubMed ID: 35941573
[TBL] [Abstract][Full Text] [Related]
4. Oxytocin for Male Subjects with Autism Spectrum Disorder and Comorbid Intellectual Disabilities: A Randomized Pilot Study.
Munesue T; Nakamura H; Kikuchi M; Miura Y; Takeuchi N; Anme T; Nanba E; Adachi K; Tsubouchi K; Sai Y; Miyamoto K; Horike S; Yokoyama S; Nakatani H; Niida Y; Kosaka H; Minabe Y; Higashida H
Front Psychiatry; 2016; 7():2. PubMed ID: 26834651
[TBL] [Abstract][Full Text] [Related]
5. Effects of multiple-dose intranasal oxytocin administration on social responsiveness in children with autism: a randomized, placebo-controlled trial.
Daniels N; Moerkerke M; Steyaert J; Bamps A; Debbaut E; Prinsen J; Tang T; Van der Donck S; Boets B; Alaerts K
Mol Autism; 2023 Apr; 14(1):16. PubMed ID: 37081454
[TBL] [Abstract][Full Text] [Related]
6. Results of a phase Ib study of SB-121, an investigational probiotic formulation, a randomized controlled trial in participants with autism spectrum disorder.
Schmitt LM; Smith EG; Pedapati EV; Horn PS; Will M; Lamy M; Barber L; Trebley J; Meyer K; Heiman M; West KHJ; Hughes P; Ahuja S; Erickson CA
Sci Rep; 2023 Mar; 13(1):5192. PubMed ID: 36997569
[TBL] [Abstract][Full Text] [Related]
7. Intranasal oxytocin treatment for social deficits and biomarkers of response in children with autism.
Parker KJ; Oztan O; Libove RA; Sumiyoshi RD; Jackson LP; Karhson DS; Summers JE; Hinman KE; Motonaga KS; Phillips JM; Carson DS; Garner JP; Hardan AY
Proc Natl Acad Sci U S A; 2017 Jul; 114(30):8119-8124. PubMed ID: 28696286
[TBL] [Abstract][Full Text] [Related]
8. Behavioral effects of multiple-dose oxytocin treatment in autism: a randomized, placebo-controlled trial with long-term follow-up.
Bernaerts S; Boets B; Bosmans G; Steyaert J; Alaerts K
Mol Autism; 2020; 11(1):6. PubMed ID: 31969977
[TBL] [Abstract][Full Text] [Related]
9. Gut to brain interaction in Autism Spectrum Disorders: a randomized controlled trial on the role of probiotics on clinical, biochemical and neurophysiological parameters.
Santocchi E; Guiducci L; Fulceri F; Billeci L; Buzzigoli E; Apicella F; Calderoni S; Grossi E; Morales MA; Muratori F
BMC Psychiatry; 2016 Jun; 16():183. PubMed ID: 27260271
[TBL] [Abstract][Full Text] [Related]
10. Clinical trial of modulatory effects of oxytocin treatment on higher-order social cognition in autism spectrum disorder: a randomized, placebo-controlled, double-blind and crossover trial.
Preckel K; Kanske P; Singer T; Paulus FM; Krach S
BMC Psychiatry; 2016 Sep; 16(1):329. PubMed ID: 27655235
[TBL] [Abstract][Full Text] [Related]
11. Intranasal oxytocin versus placebo in the treatment of adults with autism spectrum disorders: a randomized controlled trial.
Anagnostou E; Soorya L; Chaplin W; Bartz J; Halpern D; Wasserman S; Wang AT; Pepa L; Tanel N; Kushki A; Hollander E
Mol Autism; 2012 Dec; 3(1):16. PubMed ID: 23216716
[TBL] [Abstract][Full Text] [Related]
12. The effects of a course of intranasal oxytocin on social behaviors in youth diagnosed with autism spectrum disorders: a randomized controlled trial.
Guastella AJ; Gray KM; Rinehart NJ; Alvares GA; Tonge BJ; Hickie IB; Keating CM; Cacciotti-Saija C; Einfeld SL
J Child Psychol Psychiatry; 2015 Apr; 56(4):444-52. PubMed ID: 25087908
[TBL] [Abstract][Full Text] [Related]
13. Intranasal oxytocin in a genetic animal model of autism.
Szabó J; Mlynár M; Feješ A; Renczés E; Borbélyová V; Ostatníková D; Celec P
Mol Psychiatry; 2024 Feb; 29(2):342-347. PubMed ID: 38102481
[TBL] [Abstract][Full Text] [Related]
14. Effect of a novel nasal oxytocin spray with enhanced bioavailability on autism: a randomized trial.
Yamasue H; Kojima M; Kuwabara H; Kuroda M; Matsumoto K; Kanai C; Inada N; Owada K; Ochi K; Ono N; Benner S; Wakuda T; Kameno Y; Inoue J; Harada T; Tsuchiya K; Umemura K; Yamauchi A; Ogawa N; Kushima I; Ozaki N; Suyama S; Saito T; Uemura Y; Hamada J; Kano Y; Honda N; Kikuchi S; Seto M; Tomita H; Miyoshi N; Matsumoto M; Kawaguchi Y; Kanai K; Ikeda M; Nakamura I; Isomura S; Hirano Y; Onitsuka T; Kosaka H; Okada T
Brain; 2022 Apr; 145(2):490-499. PubMed ID: 35067719
[TBL] [Abstract][Full Text] [Related]
15. Safety, effectiveness, and economic evaluation of an herbal medicine, Ukgansangajinpibanha granule, in children with autism spectrum disorder: a study protocol for a prospective, multicenter, randomized, double-blinded, placebo-controlled, parallel-group clinical trial.
Lee SH; Shin S; Kim TH; Kim SM; Do TY; Park S; Lee B; Shin HJ; Lee J; Lee JY; Chang GT
Trials; 2019 Jul; 20(1):434. PubMed ID: 31307524
[TBL] [Abstract][Full Text] [Related]
16. Can repeated intranasal oxytocin administration affect reduced neural sensitivity towards expressive faces in autism? A randomized controlled trial.
Moerkerke M; Daniels N; Van der Donck S; Tibermont L; Tang T; Debbaut E; Bamps A; Prinsen J; Steyaert J; Alaerts K; Boets B
J Child Psychol Psychiatry; 2023 Nov; 64(11):1583-1595. PubMed ID: 37278339
[TBL] [Abstract][Full Text] [Related]
17. Social memory, amnesia, and autism: brain oxytocin secretion is regulated by NAD+ metabolites and single nucleotide polymorphisms of CD38.
Higashida H; Yokoyama S; Huang JJ; Liu L; Ma WJ; Akther S; Higashida C; Kikuchi M; Minabe Y; Munesue T
Neurochem Int; 2012 Nov; 61(6):828-38. PubMed ID: 22366648
[TBL] [Abstract][Full Text] [Related]
18. The Effects of Limosilactobacillus reuteri LR-99 Supplementation on Body Mass Index, Social Communication, Fine Motor Function, and Gut Microbiome Composition in Individuals with Prader-Willi Syndrome: a Randomized Double-Blinded Placebo-Controlled Trial.
Kong XJ; Liu K; Zhuang P; Tian R; Liu S; Clairmont C; Lin X; Sherman H; Zhu J; Wang Y; Fong M; Li A; Wang BK; Wang J; Yu Z; Shen C; Cui X; Cao H; Du T; Wan G; Cao X
Probiotics Antimicrob Proteins; 2021 Dec; 13(6):1508-1520. PubMed ID: 34115318
[TBL] [Abstract][Full Text] [Related]
19. The oxytocin receptor gene polymorphism rs2268491 and serum oxytocin alterations are indicative of autism spectrum disorder: A case-control paediatric study in Iraq with personalized medicine implications.
Al-Ali Z; Yasseen AA; Al-Dujailli A; Al-Karaqully AJ; McAllister KA; Jumaah AS
PLoS One; 2022; 17(3):e0265217. PubMed ID: 35316293
[TBL] [Abstract][Full Text] [Related]
20. Oral Administration of Oxytocin, Like Intranasal Administration, Decreases Top-Down Social Attention.
Zhuang Q; Zheng X; Yao S; Zhao W; Becker B; Xu X; Kendrick KM
Int J Neuropsychopharmacol; 2022 Nov; 25(11):912-923. PubMed ID: 36053298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
